FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2352805475> ?p ?o ?g. }

• W2352805475 endingPage "110" @default.
• W2352805475 startingPage "99" @default.
• W2352805475 abstract "Tumor side population (SP) cells display stem-like properties that can be modulated by treatment with the calcium channel blocker verapamil. Verapamil can enhance the cytotoxic effects of chemotherapeutic drugs and multidrug resistance by targeting the transport function of the P-glycoprotein (P-gp). This study focused on the therapeutic potential of verapamil on stem-like SP tumor cells, and further investigated its chemosensitizing effects using L3.6pl and AsPC-1 pancreatic carcinoma models. As compared to parental L3.6pl cells (0.9±0.22%), L3.6pl gemcitabine-resistant cells (L3.6plGres) showed a significantly higher percentage of SP cells (5.38±0.99%) as detected by Hoechst 33342/FACS assays. The L3.6plGres SP cells showed stable gemcitabine resistance, enhanced colony formation ability and increased tumorigenicity. Verapamil effectively inhibited L3.6plGres and AsPC-1 SP cell proliferation in vitro. A pro-apoptotic effect of verapamil was observed in L3.6pl cells, but not in L3.6plGres cells, which was linked to their differential expression of P-gp and equilibrative nucleoside transporter-1 (ENT-1). In an orthotopic pancreatic cancer mouse model, both low and high dose verapamil was shown to substantially reduce L3.6plGres-SP cell tumor growth and metastasis, enhance tumor apoptosis, and reduce microvascular density." @default.
• W2352805475 created "2016-06-24" @default.
• W2352805475 creator A5002924973 @default.
• W2352805475 creator A5014518109 @default.
• W2352805475 creator A5023256445 @default.
• W2352805475 creator A5028215404 @default.
• W2352805475 creator A5034254930 @default.
• W2352805475 creator A5048356727 @default.
• W2352805475 creator A5064932488 @default.
• W2352805475 creator A5076996542 @default.
• W2352805475 creator A5079225181 @default.
• W2352805475 creator A5079596808 @default.
• W2352805475 creator A5084638192 @default.
• W2352805475 creator A5091621849 @default.
• W2352805475 date "2016-05-10" @default.
• W2352805475 modified "2023-10-18" @default.
• W2352805475 title "Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells" @default.
• W2352805475 cites W1029507972 @default.
• W2352805475 cites W1233353675 @default.
• W2352805475 cites W1434327692 @default.
• W2352805475 cites W1483167997 @default.
• W2352805475 cites W1492396077 @default.
• W2352805475 cites W1545285984 @default.
• W2352805475 cites W1595506167 @default.
• W2352805475 cites W1889699602 @default.
• W2352805475 cites W1970572671 @default.
• W2352805475 cites W1971072079 @default.
• W2352805475 cites W1972620500 @default.
• W2352805475 cites W1982109318 @default.
• W2352805475 cites W1982180093 @default.
• W2352805475 cites W1990456739 @default.
• W2352805475 cites W1994605120 @default.
• W2352805475 cites W1995837249 @default.
• W2352805475 cites W2008449321 @default.
• W2352805475 cites W2010317454 @default.
• W2352805475 cites W2011994267 @default.
• W2352805475 cites W2012927537 @default.
• W2352805475 cites W2016886090 @default.
• W2352805475 cites W2018429029 @default.
• W2352805475 cites W2023427658 @default.
• W2352805475 cites W2026768427 @default.
• W2352805475 cites W2028791488 @default.
• W2352805475 cites W2030628127 @default.
• W2352805475 cites W2031008375 @default.
• W2352805475 cites W2031731215 @default.
• W2352805475 cites W2032621729 @default.
• W2352805475 cites W2037107824 @default.
• W2352805475 cites W2039767026 @default.
• W2352805475 cites W2042157101 @default.
• W2352805475 cites W2046025363 @default.
• W2352805475 cites W2052274640 @default.
• W2352805475 cites W2062703811 @default.
• W2352805475 cites W2076174476 @default.
• W2352805475 cites W2077841029 @default.
• W2352805475 cites W2081013078 @default.
• W2352805475 cites W2081447858 @default.
• W2352805475 cites W2085110456 @default.
• W2352805475 cites W2089424943 @default.
• W2352805475 cites W2098142549 @default.
• W2352805475 cites W2100304286 @default.
• W2352805475 cites W2101017561 @default.
• W2352805475 cites W2101995865 @default.
• W2352805475 cites W2107622792 @default.
• W2352805475 cites W2114735110 @default.
• W2352805475 cites W2117569814 @default.
• W2352805475 cites W2131555383 @default.
• W2352805475 cites W2131821411 @default.
• W2352805475 cites W2137227557 @default.
• W2352805475 cites W2137956382 @default.
• W2352805475 cites W2138778346 @default.
• W2352805475 cites W2142807621 @default.
• W2352805475 cites W2155703416 @default.
• W2352805475 cites W2163368401 @default.
• W2352805475 cites W2167960944 @default.
• W2352805475 cites W2399799438 @default.
• W2352805475 cites W2414374160 @default.
• W2352805475 cites W34802234 @default.
• W2352805475 cites W56691016 @default.
• W2352805475 cites W59619088 @default.
• W2352805475 cites W84182309 @default.
• W2352805475 doi "https://doi.org/10.3892/ijo.2016.3512" @default.
• W2352805475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4902079" @default.
• W2352805475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27177126" @default.
• W2352805475 hasPublicationYear "2016" @default.
• W2352805475 type Work @default.
• W2352805475 sameAs 2352805475 @default.
• W2352805475 citedByCount "43" @default.
• W2352805475 countsByYear W23528054752017 @default.
• W2352805475 countsByYear W23528054752018 @default.
• W2352805475 countsByYear W23528054752019 @default.
• W2352805475 countsByYear W23528054752020 @default.
• W2352805475 countsByYear W23528054752021 @default.
• W2352805475 countsByYear W23528054752022 @default.
• W2352805475 countsByYear W23528054752023 @default.
• W2352805475 crossrefType "journal-article" @default.
• W2352805475 hasAuthorship W2352805475A5002924973 @default.
• W2352805475 hasAuthorship W2352805475A5014518109 @default.
• W2352805475 hasAuthorship W2352805475A5023256445 @default.

• next